119 related articles for article (PubMed ID: 12652618)
21. Expression of E-cadherin, cadherin-11, alpha-, beta- and gamma-catenins in nephroblastomas: relationship with clinicopathological parameters, prognostic factors and outcome.
Ramburan A; Hadley GP; Govender D
Pathology; 2006 Feb; 38(1):39-44. PubMed ID: 16484007
[TBL] [Abstract][Full Text] [Related]
22. Characterization and inhibition of fatty acid synthase in pediatric tumor cell lines.
Slade RF; Hunt DA; Pochet MM; Venema VJ; Hennigar RA
Anticancer Res; 2003; 23(2B):1235-43. PubMed ID: 12820377
[TBL] [Abstract][Full Text] [Related]
23. [Renal neoplasms in children].
Sawicz-Birkowska K; Czernik J; Bagłaj M; Czauderna P; Kantorowicz-Szymik S; Poznański WA; Mańkowski P; Madziara W; Prokurat A; Osemlak J
Przegl Lek; 2004; 61 Suppl 2():20-3. PubMed ID: 15686041
[TBL] [Abstract][Full Text] [Related]
24. Fatty acid synthase (FAS) is a marker of increased risk of recurrence in lung carcinoma.
Visca P; Sebastiani V; Botti C; Diodoro MG; Lasagni RP; Romagnoli F; Brenna A; De Joannon BC; Donnorso RP; Lombardi G; Alo PL
Anticancer Res; 2004; 24(6):4169-73. PubMed ID: 15736468
[TBL] [Abstract][Full Text] [Related]
25. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
Menendez JA; Lupu R
Int J Mol Med; 2005 Jan; 15(1):33-40. PubMed ID: 15583825
[TBL] [Abstract][Full Text] [Related]
26. High telomerase RNA expression level is an adverse prognostic factor for favorable-histology Wilms' tumor.
Dome JS; Bockhold CA; Li SM; Baker SD; Green DM; Perlman EJ; Hill DA; Breslow NE
J Clin Oncol; 2005 Dec; 23(36):9138-45. PubMed ID: 16172460
[TBL] [Abstract][Full Text] [Related]
27. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
28. The significance of VEGF-C/VEGFR-2 interaction in the neovascularization and prognosis of nephroblastoma (Wilms' tumour).
Nowicki M; Ostalska-Nowicka D; Kaczmarek M; Miskowiak B; Witt M
Histopathology; 2007 Feb; 50(3):358-64. PubMed ID: 17257131
[TBL] [Abstract][Full Text] [Related]
29. Fatty acid synthase expression in squamous cell carcinoma of the tongue: clinicopathological findings.
Silva SD; Perez DE; Nishimoto IN; Alves FA; Pinto CA; Kowalski LP; Graner E
Oral Dis; 2008 May; 14(4):376-82. PubMed ID: 18410580
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma.
Phuoc NB; Ehara H; Gotoh T; Nakano M; Yokoi S; Deguchi T; Hirose Y
Urology; 2007 May; 69(5):843-8. PubMed ID: 17482919
[TBL] [Abstract][Full Text] [Related]
31. Amplification and expression of EGFR and ERBB2 in Wilms tumor.
Vasei M; Modjtahedi H; Ale-Booyeh O; Mosallaei A; Kajbafzadeh AM; Shahriari M; Ghaderi AA; Soleymanpour H; Kosari F; Moch H; Sauter G
Cancer Genet Cytogenet; 2009 Oct; 194(2):88-95. PubMed ID: 19781441
[TBL] [Abstract][Full Text] [Related]
32. Increased fatty acid synthase expression and activity during progression of prostate cancer in the TRAMP model.
Pflug BR; Pecher SM; Brink AW; Nelson JB; Foster BA
Prostate; 2003 Nov; 57(3):245-54. PubMed ID: 14518031
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of fatty acid synthase-dependent neoplastic lipogenesis as the mechanism of gamma-linolenic acid-induced toxicity to tumor cells: an extension to Nwankwo's hypothesis.
Menendez JA; Colomer R; Lupu R
Med Hypotheses; 2005; 64(2):337-41. PubMed ID: 15607568
[TBL] [Abstract][Full Text] [Related]
34. The expression of HSP70 and HSP90alpha in children with Wilms tumor.
Yang Y; Niu ZB; Hou Y; Wang CL
J Pediatr Surg; 2006 Jun; 41(6):1062-6. PubMed ID: 16769335
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.
Menendez JA; Oza BP; Atlas E; Verma VA; Mehmi I; Lupu R
Oncogene; 2004 Jun; 23(28):4945-58. PubMed ID: 15094777
[TBL] [Abstract][Full Text] [Related]
36. Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma.
Mendrzyk F; Korshunov A; Benner A; Toedt G; Pfister S; Radlwimmer B; Lichter P
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2070-9. PubMed ID: 16609018
[TBL] [Abstract][Full Text] [Related]
37. Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis.
Miyata Y; Iwata T; Ohba K; Kanda S; Nishikido M; Kanetake H
Clin Cancer Res; 2006 Dec; 12(23):6998-7003. PubMed ID: 17145820
[TBL] [Abstract][Full Text] [Related]
38. [Expression of epidermal fatty acid-binding protein and fatty acid synthase in infiltrating ductal breast carcinoma].
Li H; Lü Q; Xue H; Dong LH; Saima N; Yang HJ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):381-4. PubMed ID: 18359695
[TBL] [Abstract][Full Text] [Related]
39. [Histopathology of nephroblastomas (author's transl)].
Harms D; Zeidler H
Klin Padiatr; 1981 May; 193(3):206-12. PubMed ID: 6267354
[TBL] [Abstract][Full Text] [Related]
40. Significance of proto-oncogene Bcl-X(S/L) expression in Wilms tumor.
Basta-Jovanović G; Radonjic V; Stolic I; Nenadovic M; Brasanac D; Jovanovic D; Radojevic-Skodric S
Ren Fail; 2005; 27(1):13-8. PubMed ID: 15717629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
